15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity

Area of Science:

• Biochemistry
• Neuroscience
• Molecular Biology

Background:

• Mutations in leucine-rich repeat kinase 2 (LRRK2) are linked to genetic Parkinson's disease (PD).
• Wild-type (WT) LRRK2 kinase activity is elevated in idiopathic PD (iPD), but its regulation is unclear.
• Stressors like mitochondrial dysfunction activate WT LRRK2, but mechanisms remain elusive.

Purpose of the Study:

• To elucidate the molecular mechanisms regulating endogenous WT LRRK2 kinase activity.
• To identify upstream regulators of LRRK2 hyperactivation in idiopathic PD.
• To explore novel therapeutic targets for Parkinson's disease.

Main Methods:

• Investigated the role of 4-hydroxynonenal (4-HNE) in LRRK2 regulation.
• Utilized biochemical assays to detect 4-HNE adducts on LRRK2.
• Employed 15-lipoxygenase (15-LO) inhibition and genetic ablation models.

Main Results:

• 4-hydroxynonenal (4-HNE) is a common response to LRRK2-activating stimuli.
• 4-HNE forms adducts with Cys2024/Cys2025 in LRRK2, increasing kinase activity.
• 15-lipoxygenase (15-LO) generates the 4-HNE that regulates LRRK2.

Conclusions:

• 15-lipoxygenase (15-LO) is an upstream regulator of pathogenic LRRK2 hyperactivation.
• Inhibiting 15-LO or targeting LRRK2 Cys2024/2025 offers potential PD therapeutic strategies.
• Lowering 4-HNE levels may modulate LRRK2 activity for PD treatment.